Analysis of Single Nucleotide Polymorphisms Implicate MTOR Signalling in the Development of New-onset Diabetes After Transplantation

Overview

Journal BBA Clin

Publisher Elsevier

Specialty Biochemistry

Date 2016 Apr 7

PMID 27051588

Citations 6

Authors

S Chand

A J McKnight

S Shabir

W Chan

J A McCaughan

A P Maxwell

L Harper

R Borrows

Affiliations

Soon will be listed here.

Abstract

Introduction: Despite excellent first year outcomes in kidney transplantation, there remain significant long-term complications related to new-onset diabetes after transplantation (NODAT). The purpose of this study was to validate the findings of previous investigations of candidate gene variants in patients undergoing a protocolised, contemporary immunosuppression regimen, using detailed serial biochemical testing to identify NODAT development.

Methods: One hundred twelve live and deceased donor renal transplant recipients were prospectively followed-up for NODAT onset, biochemical testing at days 7, 90, and 365 after transplantation. Sixty-eight patients were included after exclusion for non-white ethnicity and pre-transplant diabetes. Literature review to identify candidate gene variants was undertaken as described previously.

Results: Over 25% of patients developed NODAT. In an adjusted model for age, sex, BMI, and BMI change over 12 months, five out of the studied 37 single nucleotide polymorphisms (SNPs) were significantly associated with NODAT: rs16936667:PRDM14 OR 10.57;95% CI 1.8-63.0;p = 0.01, rs1801282:PPARG OR 8.5; 95% CI 1.4-52.7; p = 0.02, rs8192678:PPARGC1A OR 0.26; 95% CI 0.08-0.91; p = 0.03, rs2144908:HNF4A OR 7.0; 95% CI 1.1-45.0;p = 0.04 and rs2340721:ATF6 OR 0.21; 95%CI 0.04-1.0; p = 0.05.

Conclusion: This study represents a replication study of candidate SNPs associated with developing NODAT and implicates mTOR as the central regulator via altered insulin sensitivity, pancreatic β cell, and mitochondrial survival and dysfunction as evidenced by the five SNPs.

General Significance: 1)Highlights the importance of careful biochemical phenotyping with oral glucose tolerance tests to diagnose NODAT in reducing time to diagnosis and missed cases.2)This alters potential genotype:phenotype association.3)The replication study generates the hypothesis that mTOR signalling pathway may be involved in NODAT development.

Citing Articles

Susceptibility Loci for Type 2 Diabetes in the Ethnically Endogamous Indian Sindhi Population: A Pooled Blood Genome-Wide Association Study.

Pipal K, Mamtani M, Patel A, Jaiswal S, Jaisinghani M, Kulkarni H Genes (Basel). 2022; 13(8).

PMID: 35893037 PMC: 9331904. DOI: 10.3390/genes13081298.

Acute D-Serine Co-Agonism of β-Cell NMDA Receptors Potentiates Glucose-Stimulated Insulin Secretion and Excitatory β-Cell Membrane Activity.

Lockridge A, Gustafson E, Wong A, Miller R, Alejandro E Cells. 2021; 10(1).

PMID: 33430405 PMC: 7826616. DOI: 10.3390/cells10010093.

Genetic Variants Associated With Immunosuppressant Pharmacokinetics and Adverse Effects in the DeKAF Genomics Genome-wide Association Studies.

Oetting W, Wu B, Schladt D, Guan W, van Setten J, Keating B Transplantation. 2019; 103(6):1131-1139.

PMID: 30801552 PMC: 6597284. DOI: 10.1097/TP.0000000000002625.

The zinc transporter Slc39a5 controls glucose sensing and insulin secretion in pancreatic β-cells via Sirt1- and Pgc-1α-mediated regulation of Glut2.

Wang X, Gao H, Wu W, Xie E, Yu Y, He X Protein Cell. 2018; 10(6):436-449.

PMID: 30324491 PMC: 6538592. DOI: 10.1007/s13238-018-0580-1.

Concepts of Genomics in Kidney Transplantation.

Oetting W, Dorr C, Remmel R, Matas A, Israni A, Jacobson P Curr Transplant Rep. 2017; 4(2):116-123.

PMID: 29123971 PMC: 5673265. DOI: 10.1007/s40472-017-0153-x.

References

Schmidt S, Mandrup S . Gene program-specific regulation of PGC-1{alpha} activity. Genes Dev. 2011; 25(14):1453-8. PMC: 3143934. DOI: 10.1101/gad.2076411. View

Chan Y, Goke J, Lu X, Venkatesan N, Feng B, Su I . A PRC2-dependent repressive role of PRDM14 in human embryonic stem cells and induced pluripotent stem cell reprogramming. Stem Cells. 2013; 31(4):682-92. DOI: 10.1002/stem.1307. View

Hara K, Tobe K, Okada T, Kadowaki H, Akanuma Y, Ito C . A genetic variation in the PGC-1 gene could confer insulin resistance and susceptibility to Type II diabetes. Diabetologia. 2002; 45(5):740-3. DOI: 10.1007/s00125-002-0803-z. View

Byrne M, Sturis J, Menzel S, Yamagata K, FAJANS S, Dronsfield M . Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12. Diabetes. 1996; 45(11):1503-10. DOI: 10.2337/diab.45.11.1503. View

Yang J, Hutchinson I, Shah T, Min D . Genetic and clinical risk factors of new-onset diabetes after transplantation in Hispanic kidney transplant recipients. Transplantation. 2011; 91(10):1114-9. DOI: 10.1097/TP.0b013e31821620f9. View

Laplante M, Sabatini D . mTOR signaling at a glance. J Cell Sci. 2009; 122(Pt 20):3589-94. PMC: 2758797. DOI: 10.1242/jcs.051011. View

Zhou J, Dhawan S, Fu H, Snyder E, Bottino R, Kundu S . Combined modulation of polycomb and trithorax genes rejuvenates β cell replication. J Clin Invest. 2013; 123(11):4849-58. PMC: 3809789. DOI: 10.1172/JCI69468. View

Lieberman M, Cunningham W . Type I and Type II error concerns in fMRI research: re-balancing the scale. Soc Cogn Affect Neurosci. 2009; 4(4):423-8. PMC: 2799956. DOI: 10.1093/scan/nsp052. View

Fougeray S, Loriot M, Nicaud V, Legendre C, Thervet E, Pallet N . Increased body mass index after kidney transplantation in activating transcription factor 6 single polymorphism gene carriers. Transplant Proc. 2011; 43(9):3418-22. DOI: 10.1016/j.transproceed.2011.09.022. View

10.

Lopes P, Fuhrmann A, Carvalho F, Sereno J, Santos M, Pereira M . Cyclosporine A enhances gluconeogenesis while sirolimus impairs insulin signaling in peripheral tissues after 3 weeks of treatment. Biochem Pharmacol. 2014; 91(1):61-73. DOI: 10.1016/j.bcp.2014.06.014. View

11.

Donath M, Ehses J, Maedler K, Schumann D, Ellingsgaard H, Eppler E . Mechanisms of beta-cell death in type 2 diabetes. Diabetes. 2005; 54 Suppl 2:S108-13. DOI: 10.2337/diabetes.54.suppl_2.s108. View

12.

Claes K, Meier-Kriesche H, Schold J, Vanrenterghem Y, Halloran P, Ekberg H . Effect of different immunosuppressive regimens on the evolution of distinct metabolic parameters: evidence from the Symphony study. Nephrol Dial Transplant. 2011; 27(2):850-7. DOI: 10.1093/ndt/gfr238. View

13.

Favaro E, Miceli I, Bussolati B, Schmitt-Ney M, Schimitt-Ney M, Cavallo Perin P . Hyperglycemia induces apoptosis of human pancreatic islet endothelial cells: effects of pravastatin on the Akt survival pathway. Am J Pathol. 2008; 173(2):442-50. PMC: 2475781. DOI: 10.2353/ajpath.2008.080238. View

14.

Barlow A, Nicholson M, Herbert T . Evidence for rapamycin toxicity in pancreatic β-cells and a review of the underlying molecular mechanisms. Diabetes. 2013; 62(8):2674-82. PMC: 3717855. DOI: 10.2337/db13-0106. View

15.

McCaughan J, McKnight A, Maxwell A . Genetics of new-onset diabetes after transplantation. J Am Soc Nephrol. 2013; 25(5):1037-49. PMC: 4005297. DOI: 10.1681/ASN.2013040383. View

16.

Thameem F, Farook V, Bogardus C, Prochazka M . Association of amino acid variants in the activating transcription factor 6 gene (ATF6) on 1q21-q23 with type 2 diabetes in Pima Indians. Diabetes. 2006; 55(3):839-42. DOI: 10.2337/diabetes.55.03.06.db05-1002. View

17.

Wang H, Maechler P, Antinozzi P, Hagenfeldt K, Wollheim C . Hepatocyte nuclear factor 4alpha regulates the expression of pancreatic beta -cell genes implicated in glucose metabolism and nutrient-induced insulin secretion. J Biol Chem. 2000; 275(46):35953-9. DOI: 10.1074/jbc.M006612200. View

18.

Blattler S, Cunningham J, Verdeguer F, Chim H, Haas W, Liu H . Yin Yang 1 deficiency in skeletal muscle protects against rapamycin-induced diabetic-like symptoms through activation of insulin/IGF signaling. Cell Metab. 2012; 15(4):505-17. PMC: 3324784. DOI: 10.1016/j.cmet.2012.03.008. View

19.

Sharif A, Moore R, Baboolal K . The use of oral glucose tolerance tests to risk stratify for new-onset diabetes after transplantation: An underdiagnosed phenomenon. Transplantation. 2007; 82(12):1667-72. DOI: 10.1097/01.tp.0000250924.99855.42. View

20.

Gu N, Ma X, Zhang J, Dong A, Jin M, Feng N . Obesity has an interactive effect with genetic variation in the activating transcription factor 6 gene on the risk of pre-diabetes in individuals of Chinese Han descent. PLoS One. 2014; 9(10):e109805. PMC: 4193822. DOI: 10.1371/journal.pone.0109805. View